Patient Guide: A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 59 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06806852
Status: 🟢 Enrolling Now
Condition: Head and Neck Squamous Cell Carcinoma
Phase: PHASE1

Where You Can Participate

This study is available at 59 locations across the country.

Top locations include:
  • • Louisville, Kentucky
  • • Minneapolis, Minnesota
  • • Columbus, Ohio
  • • And 56 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone - Join Clinical Trial NCTNCT06806852

How to Join This Clinical Trial - NCTNCT06806852

Learn how to participate in this PHASE1 trial studying an investigational therapy for Head and Neck Squamous Cell Carcinoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Head and Neck Squamous Cell Carcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Head and Neck Squamous Cell Carcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06806852 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 59 locations. Find a study site near you:

Clinical Research Site

Louisville, Kentucky 40202 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Minneapolis, Minnesota 55455 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Columbus, Ohio 43210 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Gosford, New South Wales 2250 - Australia

Status: NOT_YET_RECRUITING

Clinical Research Site

Geelong, Victoria 3220 - Australia

Status: RECRUITING

Clinical Research Site

Barretos, 14784-400 - Brazil

Status: RECRUITING

Clinical Research Site

Natal, 59062-000 - Brazil

Status: RECRUITING

Clinical Research Site

São José do Rio Preto, 15090-000 - Brazil

Status: RECRUITING

Clinical Research Site

Sofia, 1404 - Bulgaria

Status: NOT_YET_RECRUITING

Clinical Research Site

Lille, 59020 - France

Status: NOT_YET_RECRUITING

And 49 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Head and Neck Squamous Cell Carcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships